Last Updated: Wednesday, July 23, 2014, 17:14
In a key discovery against HIV, researchers have shown that an anti-cancer drug can activate hidden HIV to levels readably detectable in the blood by standard methods.
Last Updated: Thursday, July 03, 2014, 13:22
Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.
Last Updated: Tuesday, December 31, 2013, 14:33
Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.
Last Updated: Thursday, September 26, 2013, 11:37
Shares of Sun Pharma Thursday closed with nearly 3 percent gains on hopes of higher sales of a key cancer drug in the US, amid reports that the drug would likely to be in shortage soon.
Last Updated: Friday, August 16, 2013, 18:04
Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.
Last Updated: Monday, August 05, 2013, 22:29
The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.
Last Updated: Sunday, August 04, 2013, 18:39
India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.
Last Updated: Friday, July 12, 2013, 14:46
The company's product is generic version of Dacogen, manufactured and sold by Eisai Inc under license from Astex Pharmaceuticals Inc, it added.
Last Updated: Wednesday, April 03, 2013, 08:50
Over 40 countries including China, Russia and Taiwan have already granted a patent for Novartis' Glivec and India now stands out as unique for not granting a patent to this incremental innovation, the statement said.
Last Updated: Tuesday, April 02, 2013, 16:04
The SC judgment caps about seven year of tussle launched by Novartis seeking patent cover for its cancer medicine Glivec.
Last Updated: Monday, April 01, 2013, 18:19
Swiss pharma major Novartis Monday said it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent plea on cancer drug Glivec.
Last Updated: Monday, April 01, 2013, 15:09
Novartis, however, said: "This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options".
more videos >>